PL2.2 - The ticking DNA clock: lifelong somatic expansion of the disease-causing DNA repeat in Huntington's disease

Value of the Information & Strength of the Argument

The talk provides a compelling and novel synthesis of single-cell genomics and human genetics to address long-standing questions in HD. The argumentation is rigorous, building from established knowledge to new data, and clearly explains the logic behind each step. The use of single-cell data to correlate CAG length with gene expression within the same patient is a powerful approach that isolates cell-autonomous effects. The proposed model of ‘acquired toxicity’ is well-supported by the data and offers a coherent explanation for the disease’s peculiar features. The speaker also acknowledges limitations and open questions, enhancing the credibility of the presentation.

Scientific Rigor, Source Quality, Title Accuracy

The presentation is scientifically rigorous, with clear methodology and appropriate references to prior work (e.g., Peggy Shelburne, Vanessa Wheeler, Ricardo Mouro Pinto, and the GeM-HD consortium). The title accurately reflects the central theme of somatic expansion as a ’ticking DNA clock’. The talk is based on original research, including a preprint mentioned for broader repeat expansion findings. The speaker is a recognized expert, and the work has likely undergone peer review (though not explicitly stated). The title is well-aligned with the content, and the talk does not overstate conclusions.

The title accurately reflects the central theme: the role of somatic expansion of the CAG repeat as a 'ticking DNA clock' in Huntington's disease.

9/10

Presentation of original research by a leading expert, based on rigorous single-cell genomics and supported by published work and preprints. The methodology is clearly described and the conclusions are carefully drawn, with appropriate caveats.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 02:00Introduction to DNA repeats and repeat expansion disorders.
• 05:00Overview of Huntington's disease: symptoms, genetics, and brain pathology.
• 10:00Description of single-cell RNA-seq approach (Drop-seq) and its application to HD.
• 15:00Discovery of somatic expansion specifically in striatal projection neurons.
• 20:00Mechanism of DNA repeat expansion via DNA repair (Msh2/Msh3).
• 25:00Mathematical modeling of expansion dynamics and identification of phase A and B.
• 30:00Gene expression changes only after expansion beyond ~150 CAGs, defining phase C.
• 35:00Implications for therapy: targeting somatic expansion rather than huntingtin lowering.

• GeM-HD consortium genome-wide association study — Identified DNA repair genes as modifiers of age at onset in Huntington's disease.
• Preprint on somatic expansion across many repeat loci (with Poruse lab) — Mentioned as ongoing work showing expansion at many genes throughout life.

• Wheeler et al. (2007) on somatic expansion in HD mice — Showed that somatic expansion occurs in mouse models and is influenced by DNA repair genes.
• Mouro Pinto et al. (2020) on MSH3 modifiers — Identified MSH3 variants that alter age at onset, supporting the role of DNA repair.

• Conventional protein toxicity model — The traditional view that the mutant huntingtin protein is directly toxic over decades is challenged by this new model, which posits that the protein is not toxic until after massive somatic expansion.